Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Squamous Cell Carcinoma 5Esophageal Neoplasms 5Neoplasms 2Margins of Excision 1Esophageal Diseases 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1

Interventions

pembrolizumab 38Bevacizumab 25Cyclophosphamide 22Blood Specimen Collection 18Nivolumab 17Carboplatin 16Standard of Care 14Paclitaxel 14atezolizumab 13Gemcitabine 13Exercise 13Pemetrexed 12Cisplatin 12Fluorouracil 11Doxorubicin 11Cetuximab 10Radiotherapy 9Oxaliplatin 9Magnetic Resonance Spectroscopy 9Leucovorin 9Docetaxel 9durvalumab 8abemaciclib 8Temozolomide 8Surveys and Questionnaires 8Rituximab 8Prednisone 8Dexamethasone 8Biopsy 8130-nm albumin-bound paclitaxel 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Esophagectomy × 90 days × Clear all
NCT07567716 2026-05-05

Infiltration Pattern of Locally Advanced ESCC

Shanghai Chest Hospital

Enrolling by invitation
30 enrolled
Gastrointestinal

Margins of Excision, Esophageal Squamous Cell Carcinoma, Neoplasms

NCT00937456 2026-04-22

Open Versus Laparoscopically-assisted Esophagectomy for Cancer

University Hospital, Lille

Phase NA Completed
207 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡